(Q33379431)

English

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hüseyin Abali

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yüksel Urün

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Berna Oksüzoğlu

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Burçin Budakoğlu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nuriye Yildirim

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tunç Güler

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gülsüm Ozet

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nurullah Zengin

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

401-406

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Involved-field radiotherapy for advanced Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

What is new in lymphoma?

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788098

21 January 2018

Identifiers

10.1080/07357900701788098

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33379431&oldid=1611997136"